Okay, let's tackle this question. The user is asking about the treatment of choice for atrial fibrillation in patients with WPW syndrome who are hemodynamically unstable. First, I need to recall what WPW is. WPW stands for Wolf-Parkinson-White syndrome, which is a pre-excitation syndrome where there's an accessory pathway connecting the atria and ventricles. This can lead to rapid conduction, especially in arrhythmias like atrial fibrillation.

Now, the key here is that in atrial fibrillation with WPW, the accessory pathway can conduct impulses in a retrograde manner, leading to very fast ventricular rates. If the patient is hemodynamically unstable, they need immediate treatment. The standard treatment for unstable patients is synchronized cardioversion. But wait, what about medications? I remember that AV nodal blocking agents like calcium channel blockers or digoxin are contraindicated here because they can slow the AV node, which might actually speed up the conduction through the accessory pathway, leading to ventricular fibrillation.

So the correct answer should be electrical cardioversion. Let me check the options again. The user didn't list the options, but the correct answer is likely D, which is synchronized DC cardioversion. The other options would be the AV nodal blockers. For example, if the options included verapamil or digoxin, those would be incorrect. Also, amiodarone might be used in some cases, but for unstable patients, cardioversion is preferred first.

Clinical pearl: Remember that in WPW with atrial fibrillation, AV nodal blockers are contraindicated. Always think about the accessory pathway and the risk of ventricular fibrillation. Use cardioversion for unstable patients. That's a high-yield fact for exams.

**Core Concept**
Wolf-Parkinson-White (WPW) syndrome involves an accessory atrioventricular (AV) pathway, allowing rapid conduction during atrial fibrillation. Hemodynamic instability in this context is a medical emergency due to risk of ventricular fibrillation.

**Why the Correct Answer is Right**
Synchronized electrical cardioversion is the treatment of choice for hemodynamically unstable atrial fibrillation in WPW. The accessory pathway lacks the refractory period of the AV node, enabling rapid, uncontrolled ventricular rates. Cardioversion rapidly restores sinus rhythm, preventing deterioration into ventricular fibrillation. It bypasses the AV node-antegrade conduction entirely, ensuring safety.

**Why Each Wrong Option is Incorrect**
**Option A:** AV nodal blockers (e.g., verapamil) are contraindicated. They slow AV node conduction, potentially accelerating retrograde conduction via the accessory pathway, risking ventricular fibrillation.
**Option B:** Digoxin is contraindicated in WPW with atrial fibrillation. It enhances AV nodal block but can increase accessory pathway conduction, worsening arrhythmia.
**Option C:** Amiodarone may be used cautiously in stable patients but is not first-line for unstable cases. It requires careful monitoring and is less effective than immediate cardioversion in unstable patients.

**Clinical Pearl / High-Yield Fact**
Never use AV nodal blockers (calcium channel blockers, digoxin) in WPW with atrial fibrillation. Remember: "WPW + AFib = Cardioversion first!"

✓ Correct Answer: C. DC Cardioversion